Following PD-1 blockade in MMRd CRC patients, those who achieve a complete response demonstrate an increase in CD8+ T effector memory cells, CD4+ T helper cells, and CD20+ B cells compared to patients with no complete response 17. This evidence concerns the gene PDCD1 and colorectal carcinoma.